Skip to main content

UCLA Cancer Center Licenses Rosetta's Resolver Software

NEW YORK (GenomeWeb News) — Rosetta Biosoftware has licensed its Resolver data-management software to the University of California, Los Angeles, the company said yesterday.
 
The school will use the software to handle data and analyze gene expression-profiling projects at the school’s Jonsson Comprehensive Cancer Center.
 
The JCCC is a treatment center that develops cancer therapies, including the breast cancer drug Herceptin, the company said.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.